HypertensionCRF SurveyNCT07760623
Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension
An observational study of Hypertension and Hypertension (HTN), run by DejthidaNathaphong at 1 site in Thailand.
Trial summary
To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypertension, Hypertension (HTN), Artery Disease
- What is being tested?
- Diameter measurement and Velocity
- How many people
- 100 participants
- Where
- 1 siteThailand
- Study dates
- 1 Oct 2026to 18 May 2027
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Hypertensive patient who underwent the radiographic measurement of structure and function of carotid artery, renal artery or femoral artery
Who may be able to join
- Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants.
- Imaging evidence of at least 1 list of
- Common carotid artery
- Renal artery
- Femoral artery
Who cannot join
- Fatal pathology and imaging
- Pediatric or pregnant participants
- Small vessel angiogram
- Intravascular endoscopy
- Intra-operative estimation
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Thailand1 site
Invstigation center
Vadhana, Bangkok, 10110
Nathaphong Dejthida, Medical Degree, 0819220662, bnnatto@gmail.com
About this study
Official title: Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)
To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.
Read the detailed description
The study of the first degree, both sides in some of the aortic branch group, the effect and/or cause of systemic arterial hypertension compared to normotension. According to the theory of systemic arterial hypertension, the arterial resistance and high blood volume flow causing systemic arterial hypertension, the cause of arterial resistance and high blood volume flow evaluation may trace back to the possible actual cause of systemic arterial hypertension by backward investigation. Despite the fact that target organ damage is the crucial maneuver of hypertension evaluation, both sides of the common carotid artery, renal artery, and femoral artery may cause systemic arterial hypertension and may imply that feasible to predict the end organ of stroke, ESRD, and amputated-type arterial occlusion, respectively.
This study belongs to 2 questions
- Can the main aortic branch be evidence of a cause of systemic arterial hypertension following high resistance and/or high fluid flow by theory?
- Can the main aortic branch be a marker of evidence of endpoint organ damage?
- Conditions
- Hypertension, Hypertension (HTN), Artery Disease, Target Organ Damage
- Being tested
- Diameter measurement, Velocity
- Keywords
- hypertension, common carotid artery, renal artery, femmoral artery, vascular resistant
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Diameter measurementOther
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery
VelocityOther
Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)
| Study group | Role | What they receive |
|---|---|---|
| Common Carotid Artery | The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Common Carotid Artery. Receives: Other: Diameter measurement; Other: Velocity | |
| Renal Artery | The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Renal Artery. Receives: Other: Diameter measurement; Other: Velocity | |
| Femoral Artery | The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Femoral Artery. Receives: Other: Diameter measurement; Other: Velocity |
What is being measured
The primary outcome is the main question the study is designed to answer.
Median of diameter of common carotid artery, renal artery and femoral artery in hypertension patients.
Radiographic measurement includes ultrasonography, CT/MR imaging, and intravascular contrast media imaging that measure the diameter in cm. unit of any side of common carotid artery and/or renal artery and/or femoral artery in hypertension patients.
Measured: 1 years
Secondary outcomes (3)
Common Carotid Artery Function
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Common Carotid Artery
Measured: 1 year
Renal Artery Function
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Renal Artery
Measured: 1 year
Femoral Artery Function
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Femoral Artery
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Aug 2026
- Study start1 Oct 2026 (estimated)
- Primary completion31 Dec 2026 (estimated)
- Study completion18 May 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- DejthidaNathaphong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nathaphong Dejthida, DejthidaNathaphong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07760623
- Sponsor's protocol ID
- NathaphongD
- Other IDs
- PROSPERO
- Acronym
- CRF Survey
- Status last verified
- Sep 2026
- First submitted
- 30 Jul 2026
- Last updated
- 1 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No